Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Diabetes, Obesity & Metabolism|February 19, 2014
Mortality risk with sulphonylureas compared to metforminS E Holden, C J Currie
Diabetes, Obesity & Metabolism|January 14, 2014
How many people inject insulin? UK estimates from 1991 to 2010S E Holden, E A M Gale, S Jenkins-Jones, et al.
Diabetes, Obesity & Metabolism|November 18, 2014
Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancerS E Holden, S Jenkins-Jones, C Ll Morgan, et al.
Diabetes, Obesity & Metabolism|April 26, 2014
Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortalityC Ll Morgan, J Mukherjee, S Jenkins-Jones, et al.
Diabetes, Obesity & Metabolism|April 12, 2014
Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational studyC Ll Morgan, J Mukherjee, S Jenkins-Jones, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery|April 4, 2021
Geriatric assessment and medical preoperative screening (GrAMPS) program for older hernia patientsBradley S Kushner, J Hamilton, B J Han, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 8, 2017
Prevalence, glucose control and relative survival of people with Type 2 diabetes in the UK from 1991 to 2013S E Holden, S Jenkins-Jones, C Ll Morgan, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery|October 23, 2021
Randomized control trial evaluating the use of a shared decision-making aid for older ventral hernia patients in the Geriatric Assessment and Medical Preoperative Screening (GrAMPS) ProgramB S Kushner, T Holden, B Han, et al.
Diabetes, Obesity & Metabolism|July 22, 2014
Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controlsC A Bannister, S E Holden, S Jenkins-Jones, et al.
Pageof 1